(RTTNews) - Spruce Biosciences, Inc. (SPRB), Monday announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to the company's tralesinidase alfa enzyme ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback